Cathy Yen

AsiaVest Partners, TCW/YFY (Taiwan) Ltd. (AsiaVest-TCW) is a joint venture between the Hong-Kong-based AsiaVest Investment Advisory Ltd., known as AVP-AsiaVest Partners, and TCW Group, Inc., which is a US-based subsidiary of Société Générale Asset Management since 2001. Established in 1995 and previously known as TCW/YFY Investment Partners Ltd., AsiaVest-TCW is headquartered in Taipei with representative offices in Shanghai and Beijing. The joint venture is a leading venture capital investor in the Greater China region. They combine the local knowledge and resources of AsiaVest's investment team with the global investment capabilities of TCW. Their clients are institutional investors worldwide, including corporate and government pension funds, sovereign states, private equity fund of funds, insurance companies and corporations in North America, Europe, Asia and Australia.

Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China.

BioDuro-Sundia develops and manufactures pharmaceutical products. The firm engages in the discovery, development and manufacturing for both API (Active Pharmaceutical Ingredients) and drug products. The company is headquartered in San Diego, CA.

Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China.

BioDuro-Sundia develops and manufactures pharmaceutical products. The firm engages in the discovery, development and manufacturing for both API (Active Pharmaceutical Ingredients) and drug products. The company is headquartered in San Diego, CA.

Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China.

Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China.

BioDuro-Sundia develops and manufactures pharmaceutical products. The firm engages in the discovery, development and manufacturing for both API (Active Pharmaceutical Ingredients) and drug products. The company is headquartered in San Diego, CA.

Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China.

Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China.

AsiaVest Partners, TCW/YFY (Taiwan) Ltd. (AsiaVest-TCW) is a joint venture between the Hong-Kong-based AsiaVest Investment Advisory Ltd., known as AVP-AsiaVest Partners, and TCW Group, Inc., which is a US-based subsidiary of Société Générale Asset Management since 2001. Established in 1995 and previously known as TCW/YFY Investment Partners Ltd., AsiaVest-TCW is headquartered in Taipei with representative offices in Shanghai and Beijing. The joint venture is a leading venture capital investor in the Greater China region. They combine the local knowledge and resources of AsiaVest's investment team with the global investment capabilities of TCW. Their clients are institutional investors worldwide, including corporate and government pension funds, sovereign states, private equity fund of funds, insurance companies and corporations in North America, Europe, Asia and Australia.

Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China.

Sundia MediTech Co., Ltd. provides drug discovery and development services. It offers research and development outsourcing services to biotech and pharmaceutical companies, ranging from chemical services, medicinal chemistry, biological services, technology platforms, and pharmaceutical development services. The company was founded in May 2004 and is headquartered in Shanghai, China.

BioDuro-Sundia develops and manufactures pharmaceutical products. The firm engages in the discovery, development and manufacturing for both API (Active Pharmaceutical Ingredients) and drug products. The company is headquartered in San Diego, CA.

AsiaVest Partners, TCW/YFY (Taiwan) Ltd. (AsiaVest-TCW) is a joint venture between the Hong-Kong-based AsiaVest Investment Advisory Ltd., known as AVP-AsiaVest Partners, and TCW Group, Inc., which is a US-based subsidiary of Société Générale Asset Management since 2001. Established in 1995 and previously known as TCW/YFY Investment Partners Ltd., AsiaVest-TCW is headquartered in Taipei with representative offices in Shanghai and Beijing. The joint venture is a leading venture capital investor in the Greater China region. They combine the local knowledge and resources of AsiaVest's investment team with the global investment capabilities of TCW. Their clients are institutional investors worldwide, including corporate and government pension funds, sovereign states, private equity fund of funds, insurance companies and corporations in North America, Europe, Asia and Australia.